521079-87-8
Chemical Structure
Tefibazumab
Synonym(s): INH-H 2002
- CAS No.: 521079-87-8
- Formula:N/A
- Molecular Weight:(147.04 kDa)
IUPAC Name: 7-methyl-3-(methyl-d3)octa-1,6-dien-4,4-d2-3-ol
SMILES: [Tefibazumab]
Biological Activity: Tefibazumab is a humanized IgG1κ monoclonal antibody that binds to the surface-expressed adhesion protein clumping factor A. Tefibazumab can be used for the research of serious Staphylococcus aureus infections[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Tefibazumab | 99.90% | Tefibazumab is a humanized IgG1κ monoclonal antibody that binds to the surface-expressed adhesion protein clumping factor A. Tefibazumab can be used for the research of serious Staphylococcus aureus infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2006 Aug;50(8):2751-5. [Content Brief]
- [2]. Reilley S, et, al. Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers. Antimicrob Agents Chemother. 2005 Mar;49(3):959-62. [Content Brief]
Keywords